169 related articles for article (PubMed ID: 19241077)
1. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
[TBL] [Abstract][Full Text] [Related]
2. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
Fuchs R; Schraml E; Leitinger G; Stelzer I; Allard N; Haas HS; Schauenstein K; Sadjak A
Exp Cell Res; 2011 Oct; 317(16):2239-51. PubMed ID: 21781962
[TBL] [Abstract][Full Text] [Related]
3. α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.
Fuchs R; Schraml E; Leitinger G; Letofsky-Papst I; Stelzer I; Haas HS; Schauenstein K; Sadjak A
Exp Cell Res; 2011 Dec; 317(20):2969-80. PubMed ID: 21851819
[TBL] [Abstract][Full Text] [Related]
4. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
5. A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation.
Cailleteau C; Liagre B; Beneytout JL
J Cell Biochem; 2009 Jul; 107(4):785-96. PubMed ID: 19415684
[TBL] [Abstract][Full Text] [Related]
6. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
7. [Effects of prazosin on the proliferation and apoptosis of K562 leukemia cells].
He J; He Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):562-5. PubMed ID: 16320589
[TBL] [Abstract][Full Text] [Related]
8. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells.
Cailleteau C; Liagre B; Battu S; Jayat-Vignoles C; Beneytout JL
Anal Biochem; 2008 Sep; 380(1):26-34. PubMed ID: 18549804
[TBL] [Abstract][Full Text] [Related]
9. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
Kim HH; Ahn KS; Han H; Choung SY; Choi SY; Kim IH
Leuk Res; 2005 Dec; 29(12):1407-13. PubMed ID: 15992925
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
11. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
12. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
Green AR; Rockman S; DeLuca E; Begley CG
Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
[TBL] [Abstract][Full Text] [Related]
13. Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells.
Terui Y; Furukawa Y; Kikuchi J; Iwase S; Hatake K; Miura Y
Exp Hematol; 1998 Mar; 26(3):236-44. PubMed ID: 9502620
[TBL] [Abstract][Full Text] [Related]
14. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
15. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
[TBL] [Abstract][Full Text] [Related]
16. CDDO-Im is a stimulator of megakaryocytic differentiation.
Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
[TBL] [Abstract][Full Text] [Related]
17. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation.
Léger DY; Battu S; Liagre B; Beneytout JL; Cardot PJ
Anal Biochem; 2006 Aug; 355(1):19-28. PubMed ID: 16806034
[TBL] [Abstract][Full Text] [Related]
19. In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.
Saulle E; Riccioni R; Pelosi E; Stafness M; Mariani G; De Tuglie G; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 36(1):59-76. PubMed ID: 16360329
[TBL] [Abstract][Full Text] [Related]
20. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.
Drexler HG; Matsuo Y; MacLeod RA
Leuk Res; 2004 Dec; 28(12):1243-51. PubMed ID: 15475063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
